Impact factor molecular cancer therapeutics
Witryna1 kwi 2024 · BRAF-Driven Pancreatic Cancer: Prevalence, Molecular Features, and Therapeutic Opportunities Last mentioned on Friday April 7 2024 Quantitative In Vivo …
Impact factor molecular cancer therapeutics
Did you know?
WitrynaJournal impact factor : 0.53 ; Average acceptance to publication time (5-7 days) Average article processing time (30-45 days) Less than 5 volumes 30 days ... Biochimica et Biophysica Acta - Reviews on Cancer, Breast Cancer Research, Neuro-Oncology, Molecular Cancer Therapeutics, Cancer, Journal of Thoracic Oncology. WitrynaMolecular Cancer Impact Factor, IF, number of article, detailed information and journal factor. ISSN: 1476-4598. ... About Molecular Cancer. Molecular Cancer is an open access, peer-reviewed online journal interested in attracting high-quality original research and reviews that present or highlight significant advances in all areas of cancer ...
WitrynaImpact Factor Cancer Discovery: 41.226 Cancer Epidemiology, Biomarkers & Prevention: 5.594 Cancer Immunology Research: 13.345 Cancer Prevention Research: 4.317 … WitrynaMolecular Research on Pancreatic Cancer: Current Trends and New Perspectives (Deadline: 15 April 2024) Kinases and Other Molecular Targets in Cancer: Recent …
WitrynaMolecular Cancer Research 是美国癌症研究学会（AACR）旗下刊物，于 2003年 创刊。. 这本期刊主要专注于癌症相关的基础研究，对于偏临床方向的文章就不太推荐投该杂志了（转而投 Cancer Research and Treatment 会更合适）。. 文章对于新颖性没有太高的要求，对于机制的 ... Witryna8 kwi 2024 · Attenuating aberrant transcriptional circuits holds great promise for the treatment of numerous diseases, including cancer. However, development of transcriptional inhibitors is hampered by the lack of a generally accepted functional cellular readout to characterize their target specificity and on-target activity. We …
WitrynaMolecular Therapy Oncolytics is an international, online-only, open-access journal focusing on the development and clinical testing of viral, cellular, and other biological therapies targeting cancer. While providing a unique forum for work in the burgeoning fields of oncolytic virotherapy, as well as T cell- and stem cell-based therapies, the …
Witryna2 dni temu · Start your submission and get more impact for your research by publishing with us. Author guidelines. Ready to publish? Check out our author guidelines for everything you need to know about submission, from choosing a journal and section to preparing your manuscript. ... Cancer Molecular Targets and Therapeutics wafik s. … how about halaraWitrynaExperience in the developmental genetic factors affecting human brain disorders, rodent and non-rodent animal models and tumor … how about grammarWitryna1 kwi 2024 · About the Journal. Molecular Cancer Therapeutics publishes articles on the discovery and preclinical development of novel therapeutic agents for oncology, preclinical studies of approved therapeutics, mechanisms of drug action, … MCT First Disclosures. First Disclosures in Molecular Cancer Therapeutics present … Channing J. Der Vishva Dixit Ethan Dmitrovsky Suzanne A. Eccles Heinz … Read Volume 21 Issue 9 of Molecular Cancer Therapeutics. Skip to Main … A Novel Anti-HER2 Antibody–Drug Conjugate XMT-1522 for HER2-Positive … Molecular Cancer Research ; Molecular Cancer Therapeutics ; For Authors . … Abstract. Loss of the gene SMARCB1 drives the development of malignant … Abstract. T-cell bispecific antibodies (TCB) are engineered molecules that bind both … Abstract. YES1 is a nonreceptor tyrosine kinase that belongs to the SRC family of … how many hamsters in the worldWitryna27 maj 2024 · The impact score (IS) 2024 of Molecular Cancer Therapeutics is 5.53, which is computed in 2024 as per its definition. Molecular Cancer Therapeutics IS is … how about having dinner at sunWitryna11 sty 2024 · The recently launched Cancer Research Communications (CRC) is the latest addition to the AACR’s journal portfolio. The new journal is open access and covers the full spectrum of cancer science and medicine, from basic and translational scientific investigations to early- and late-phase clinical trials, epidemiologic studies, and … how many hamish missions rdr2WitrynaAs an Institutional postdoctoral researcher in different academic institutes, I hold an excellent command in the field of Molecular biology, Molecular analysis technology, RNA biology, Cell biology, Genetics & Genomics especially in novel platforms for therapeutics, molecular targets driving Cancer Drug Resistance for potential … —how about having a drinkWitryna6 paź 2024 · In this Editorial, Christine Watson highlights the content of The FEBS Journal ’s Special Issue on Cancer Therapeutics. Through an exciting collection of recent articles, this issue covers a broad repertoire of cancer therapeutic approaches. Several articles discuss broad-spectrum applications, such as immunotherapy and … how many hampton inns are in usa